Beta-Amyloid (1-42) • HFIP

Overview

When it comes to studying beta-amyloid peptides, the Beta-Amyloid (1-42) • HFIP from AnaSpec is your ideal choice. This peptide is specifically designed for researchers focused on Alzheimer’s disease and related studies. The HFIP treatment process allows for the effective breakdown of preexisting structures in lyophilized Aβ-peptide stocks, paving the way for controlled aggregation studies. By utilizing HFIP, you achieve a dense and homogeneous preparation of unaggregated peptide, ensuring that your samples are reliable for experimentation.

Key Features

• Designed for Alzheimer’s research and controlled aggregation studies.
• HFIP treatment eliminates preexisting structures in lyophilized Aβ-peptide stocks.
• Leads to a dense, homogeneous preparation of unaggregated peptide.
• Samples can be stored conveniently as peptide films.
• Enables effective study of β-sheet structure and α-helical secondary structure transitions.

Specifications

FAQ

What is HFIP and why is it used?

HFIP, or hexafluoroisopropanol, is a solvent known for breaking down β-sheet structures and disrupting hydrophobic forces. This makes it crucial for preparing amyloid peptides for study.

How should I store the Beta-Amyloid (1-42) • HFIP?

Once treated with HFIP, the peptide can be stored as films, which helps maintain its integrity for future use.

Can I use Beta-Amyloid (1-42) • HFIP in aggregation studies?

Yes, this product is specifically designed for controlled aggregation studies, allowing for a detailed analysis of amyloid behavior.

For more peptides suitable for various research applications, check out our wide selection of peptides. Each product is formulated with precision to meet the needs of the research community. Don’t miss the opportunity to enhance your studies; add Beta-Amyloid (1-42) • HFIP to your cart today!

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled